Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Trading Company
Tel: +86-371- 86259723
Tel: 17734809689
Tel: 17734809689
Tel: 86-371-86259723
Tel: 17734809689
Tel: 17734809689
Mobile: 17734809689
Tel: +86-371- 86259723
Fax: +86-371- 86259723
Province/state: HENAN
City: ZHENGZHOU
Street: Mingmen International Center, NO.222 Dongming Road,Zhengzhou,Henan,China
MaxCard:
CAS NO.125995-03-1
Atorvastatin lactone Basic information |
Product Name: | Atorvastatin lactone |
Synonyms: | ATORVASTATIN LACTONE;5-(4-Fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide;Atorvastatin d-Lactone;(4R,6R)-6-{2-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl}-4-hydroxytetrahydro-2H-pyran-2-one;(3R,5R)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-yl]-3,5-dihydroxyheptanoic acid 1,5-lactone;1-[2-[[(2R)-Tetrahydro-4β-hydroxy-6-oxo-2H-pyran]-2α-yl]ethyl]-5-(4-fluorophenyl)-2-isopropyl-4,N-diphenyl-1H-pyrrole-3-carboxamide;Atorvastatin Related Compound H (20 mg) (5-(4-Fluorophenyl)-1-{2-[(2R, 4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide);Atorvastatin EPIMp H (USP RCH) |
CAS: | 125995-03-1 |
MF: | C33H33FN2O4 |
MW: | 540.63 |
EINECS: | |
Product Categories: | Inhibitors;Intermediates & Fine Chemicals;Metabolites & Impurities;Pharmaceuticals |
Mol File: | 125995-03-1.mol |
Atorvastatin lactone Chemical Properties |
mp | 103-106°C |
storage temp. | -20°C Freezer, Under Inert Atmosphere |
Safety Information |
Atorvastatin lactone Usage And Synthesis |
Chemical Properties | Slightly Yellow Solid |
Usage | Atorvastatin intermediate as inhibitor of MAP kinase and/or HMG-CoA reductase for the treatment of inflammation |
Atorvastatin lactone Basic information |
Product Name: | Atorvastatin lactone |
Synonyms: | ATORVASTATIN LACTONE;5-(4-Fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide;Atorvastatin d-Lactone;(4R,6R)-6-{2-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl}-4-hydroxytetrahydro-2H-pyran-2-one;(3R,5R)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-yl]-3,5-dihydroxyheptanoic acid 1,5-lactone;1-[2-[[(2R)-Tetrahydro-4β-hydroxy-6-oxo-2H-pyran]-2α-yl]ethyl]-5-(4-fluorophenyl)-2-isopropyl-4,N-diphenyl-1H-pyrrole-3-carboxamide;Atorvastatin Related Compound H (20 mg) (5-(4-Fluorophenyl)-1-{2-[(2R, 4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide);Atorvastatin EPIMp H (USP RCH) |
CAS: | 125995-03-1 |
MF: | C33H33FN2O4 |
MW: | 540.63 |
EINECS: | |
Product Categories: | Inhibitors;Intermediates & Fine Chemicals;Metabolites & Impurities;Pharmaceuticals |
Mol File: | 125995-03-1.mol |
Atorvastatin lactone Chemical Properties |
mp | 103-106°C |
storage temp. | -20°C Freezer, Under Inert Atmosphere |
Safety Information |
Atorvastatin lactone Usage And Synthesis |
Chemical Properties | Slightly Yellow Solid |
Usage | Atorvastatin intermediate as inhibitor of MAP kinase and/or HMG-CoA reductase for the treatment of inflammation |